Ovarian hematoma and hemoperitoneum complicating anticoagulant therapy.
The diagnosis and management of ovarian hemorrhage complicating anticoagulant therapy is discussed and a case presented. The patient, who had undergone mitral valve replacement and was receiving chronic anticoagulation treatment, was admitted with signs of intraperitoneal bleeding from a ruptured ovarian hematoma. This complication must be considered in the menstruating female who is receiving anticoagulant therapy. Long-term anovulatory therapy could possibly avoid this potential ovarian hemorrhage.
D000328:Adult; D005260:Female; D006406:Hematoma / Q000139:chemically induced*; D006465:Hemoperitoneum / Q000139:chemically induced*; D006801:Humans; D008598:Menstruation; D010049:Ovarian Diseases / Q000139:chemically induced*; D014859:Warfarin / Q000009:adverse effects*
D014859:Warfarin